Company intelligence / Profile preview
Integrated Nanotherapeutics
Burnaby / Vancouver, British Columbia, Canadaintegratedntx.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Integrated Nanotherapeutics has developed a proprietary LNP-based platform capable of delivering multiple therapeutic modalities—including mRNA and small molecule immunomodulators—to induce antigen-specific immune tolerance. Their lead program targets type 1 diabetes and is currently in preclinical development with support from Breakthrough T1D. The company’s founding team has contributed to the development of five approved LNP drugs.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small moleculesBiologics (including mRNA, siRNA, peptides)Lipid nanoparticles (LNPs) as delivery vehicles
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Breakthrough T1D (formerly JDRF), supporting preclinical work on type 1 diabetes tolerizing therapyAcademic collaborations implied but not individually named; open to industry/academic partnerships
Beyond the preview
Go deeper on Integrated Nanotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Integrated Nanotherapeutics.